The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Inhalation Powder Budesonide Market Research Report 2025
Synopsis
Inhalation Powder is white to off-white round particles, lightly pressed into powder, filled into a special multi-dose powder inhaler driven by inhalation airflow.
The global Inhalation Powder Budesonide market was valued at US$ 1148.4 million in 2023 and is anticipated to reach US$ 1651 million by 2030, witnessing a CAGR of 5.4% during the forecast period 2024-2030.
North American market for Inhalation Powder Budesonide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Inhalation Powder Budesonide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Inhalation Powder Budesonide include AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation and Cipla, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Inhalation Powder Budesonide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhalation Powder Budesonide.
Report Scope
The Inhalation Powder Budesonide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inhalation Powder Budesonide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhalation Powder Budesonide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Teva
Mylan
Sandoz
Cosmo Pharmaceuticals
Salix
Chiesi Farmaceutici
Orion Corporation
Cipla
Synmosa Biopharma
Lunan Better Pharma
Shanghai Sine Promod
Segment by Type
100~200 Inhalation
Other
Segment by Application
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inhalation Powder Budesonide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inhalation Powder Budesonide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Inhalation Powder is white to off-white round particles, lightly pressed into powder, filled into a special multi-dose powder inhaler driven by inhalation airflow.
The global Inhalation Powder Budesonide market was valued at US$ 1148.4 million in 2023 and is anticipated to reach US$ 1651 million by 2030, witnessing a CAGR of 5.4% during the forecast period 2024-2030.
North American market for Inhalation Powder Budesonide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Inhalation Powder Budesonide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Inhalation Powder Budesonide include AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation and Cipla, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Inhalation Powder Budesonide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhalation Powder Budesonide.
Report Scope
The Inhalation Powder Budesonide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inhalation Powder Budesonide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhalation Powder Budesonide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Teva
Mylan
Sandoz
Cosmo Pharmaceuticals
Salix
Chiesi Farmaceutici
Orion Corporation
Cipla
Synmosa Biopharma
Lunan Better Pharma
Shanghai Sine Promod
Segment by Type
100~200 Inhalation
Other
Segment by Application
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inhalation Powder Budesonide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inhalation Powder Budesonide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Inhalation Powder Budesonide Market Overview
1.1 Product Overview and Scope of Inhalation Powder Budesonide
1.2 Inhalation Powder Budesonide Segment by Type
1.2.1 Global Inhalation Powder Budesonide Market Value Comparison by Type (2024-2030)
1.2.2 100~200 Inhalation
1.2.3 Other
1.3 Inhalation Powder Budesonide Segment by Application
1.3.1 Global Inhalation Powder Budesonide Market Value by Application: (2024-2030)
1.3.2 Respiratory Disease Treatment
1.3.3 Nose Disease Treatment
1.3.4 Inflammatory Bowel Disease Treatment
1.3.5 Other
1.4 Global Inhalation Powder Budesonide Market Size Estimates and Forecasts
1.4.1 Global Inhalation Powder Budesonide Revenue 2019-2030
1.4.2 Global Inhalation Powder Budesonide Sales 2019-2030
1.4.3 Global Inhalation Powder Budesonide Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Inhalation Powder Budesonide Market Competition by Manufacturers
2.1 Global Inhalation Powder Budesonide Sales Market Share by Manufacturers (2019-2024)
2.2 Global Inhalation Powder Budesonide Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Inhalation Powder Budesonide Average Price by Manufacturers (2019-2024)
2.4 Global Inhalation Powder Budesonide Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Inhalation Powder Budesonide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inhalation Powder Budesonide, Product Type & Application
2.7 Inhalation Powder Budesonide Market Competitive Situation and Trends
2.7.1 Inhalation Powder Budesonide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Inhalation Powder Budesonide Players Market Share by Revenue
2.7.3 Global Inhalation Powder Budesonide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Inhalation Powder Budesonide Retrospective Market Scenario by Region
3.1 Global Inhalation Powder Budesonide Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Inhalation Powder Budesonide Global Inhalation Powder Budesonide Sales by Region: 2019-2030
3.2.1 Global Inhalation Powder Budesonide Sales by Region: 2019-2024
3.2.2 Global Inhalation Powder Budesonide Sales by Region: 2025-2030
3.3 Global Inhalation Powder Budesonide Global Inhalation Powder Budesonide Revenue by Region: 2019-2030
3.3.1 Global Inhalation Powder Budesonide Revenue by Region: 2019-2024
3.3.2 Global Inhalation Powder Budesonide Revenue by Region: 2025-2030
3.4 North America Inhalation Powder Budesonide Market Facts & Figures by Country
3.4.1 North America Inhalation Powder Budesonide Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Inhalation Powder Budesonide Sales by Country (2019-2030)
3.4.3 North America Inhalation Powder Budesonide Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Inhalation Powder Budesonide Market Facts & Figures by Country
3.5.1 Europe Inhalation Powder Budesonide Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Inhalation Powder Budesonide Sales by Country (2019-2030)
3.5.3 Europe Inhalation Powder Budesonide Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inhalation Powder Budesonide Market Facts & Figures by Country
3.6.1 Asia Pacific Inhalation Powder Budesonide Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Inhalation Powder Budesonide Sales by Country (2019-2030)
3.6.3 Asia Pacific Inhalation Powder Budesonide Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Inhalation Powder Budesonide Market Facts & Figures by Country
3.7.1 Latin America Inhalation Powder Budesonide Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Inhalation Powder Budesonide Sales by Country (2019-2030)
3.7.3 Latin America Inhalation Powder Budesonide Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inhalation Powder Budesonide Market Facts & Figures by Country
3.8.1 Middle East and Africa Inhalation Powder Budesonide Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Inhalation Powder Budesonide Sales by Country (2019-2030)
3.8.3 Middle East and Africa Inhalation Powder Budesonide Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Inhalation Powder Budesonide Sales by Type (2019-2030)
4.1.1 Global Inhalation Powder Budesonide Sales by Type (2019-2024)
4.1.2 Global Inhalation Powder Budesonide Sales by Type (2025-2030)
4.1.3 Global Inhalation Powder Budesonide Sales Market Share by Type (2019-2030)
4.2 Global Inhalation Powder Budesonide Revenue by Type (2019-2030)
4.2.1 Global Inhalation Powder Budesonide Revenue by Type (2019-2024)
4.2.2 Global Inhalation Powder Budesonide Revenue by Type (2025-2030)
4.2.3 Global Inhalation Powder Budesonide Revenue Market Share by Type (2019-2030)
4.3 Global Inhalation Powder Budesonide Price by Type (2019-2030)
5 Segment by Application
5.1 Global Inhalation Powder Budesonide Sales by Application (2019-2030)
5.1.1 Global Inhalation Powder Budesonide Sales by Application (2019-2024)
5.1.2 Global Inhalation Powder Budesonide Sales by Application (2025-2030)
5.1.3 Global Inhalation Powder Budesonide Sales Market Share by Application (2019-2030)
5.2 Global Inhalation Powder Budesonide Revenue by Application (2019-2030)
5.2.1 Global Inhalation Powder Budesonide Revenue by Application (2019-2024)
5.2.2 Global Inhalation Powder Budesonide Revenue by Application (2025-2030)
5.2.3 Global Inhalation Powder Budesonide Revenue Market Share by Application (2019-2030)
5.3 Global Inhalation Powder Budesonide Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AstraZeneca Inhalation Powder Budesonide Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Inhalation Powder Budesonide Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mylan Inhalation Powder Budesonide Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Sandoz
6.4.1 Sandoz Corporation Information
6.4.2 Sandoz Description and Business Overview
6.4.3 Sandoz Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sandoz Inhalation Powder Budesonide Product Portfolio
6.4.5 Sandoz Recent Developments/Updates
6.5 Cosmo Pharmaceuticals
6.5.1 Cosmo Pharmaceuticals Corporation Information
6.5.2 Cosmo Pharmaceuticals Description and Business Overview
6.5.3 Cosmo Pharmaceuticals Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cosmo Pharmaceuticals Inhalation Powder Budesonide Product Portfolio
6.5.5 Cosmo Pharmaceuticals Recent Developments/Updates
6.6 Salix
6.6.1 Salix Corporation Information
6.6.2 Salix Description and Business Overview
6.6.3 Salix Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Salix Inhalation Powder Budesonide Product Portfolio
6.6.5 Salix Recent Developments/Updates
6.7 Chiesi Farmaceutici
6.6.1 Chiesi Farmaceutici Corporation Information
6.6.2 Chiesi Farmaceutici Description and Business Overview
6.6.3 Chiesi Farmaceutici Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chiesi Farmaceutici Inhalation Powder Budesonide Product Portfolio
6.7.5 Chiesi Farmaceutici Recent Developments/Updates
6.8 Orion Corporation
6.8.1 Orion Corporation Corporation Information
6.8.2 Orion Corporation Description and Business Overview
6.8.3 Orion Corporation Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Orion Corporation Inhalation Powder Budesonide Product Portfolio
6.8.5 Orion Corporation Recent Developments/Updates
6.9 Cipla
6.9.1 Cipla Corporation Information
6.9.2 Cipla Description and Business Overview
6.9.3 Cipla Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Cipla Inhalation Powder Budesonide Product Portfolio
6.9.5 Cipla Recent Developments/Updates
6.10 Synmosa Biopharma
6.10.1 Synmosa Biopharma Corporation Information
6.10.2 Synmosa Biopharma Description and Business Overview
6.10.3 Synmosa Biopharma Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Synmosa Biopharma Inhalation Powder Budesonide Product Portfolio
6.10.5 Synmosa Biopharma Recent Developments/Updates
6.11 Lunan Better Pharma
6.11.1 Lunan Better Pharma Corporation Information
6.11.2 Lunan Better Pharma Inhalation Powder Budesonide Description and Business Overview
6.11.3 Lunan Better Pharma Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Lunan Better Pharma Inhalation Powder Budesonide Product Portfolio
6.11.5 Lunan Better Pharma Recent Developments/Updates
6.12 Shanghai Sine Promod
6.12.1 Shanghai Sine Promod Corporation Information
6.12.2 Shanghai Sine Promod Inhalation Powder Budesonide Description and Business Overview
6.12.3 Shanghai Sine Promod Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Shanghai Sine Promod Inhalation Powder Budesonide Product Portfolio
6.12.5 Shanghai Sine Promod Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inhalation Powder Budesonide Industry Chain Analysis
7.2 Inhalation Powder Budesonide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inhalation Powder Budesonide Production Mode & Process
7.4 Inhalation Powder Budesonide Sales and Marketing
7.4.1 Inhalation Powder Budesonide Sales Channels
7.4.2 Inhalation Powder Budesonide Distributors
7.5 Inhalation Powder Budesonide Customers
8 Inhalation Powder Budesonide Market Dynamics
8.1 Inhalation Powder Budesonide Industry Trends
8.2 Inhalation Powder Budesonide Market Drivers
8.3 Inhalation Powder Budesonide Market Challenges
8.4 Inhalation Powder Budesonide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Inhalation Powder Budesonide Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Inhalation Powder Budesonide Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Inhalation Powder Budesonide Market Competitive Situation by Manufacturers in 2023
Table 4. Global Inhalation Powder Budesonide Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Inhalation Powder Budesonide Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Inhalation Powder Budesonide Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Inhalation Powder Budesonide Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Inhalation Powder Budesonide Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Inhalation Powder Budesonide, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Inhalation Powder Budesonide, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Inhalation Powder Budesonide, Product Type & Application
Table 12. Global Key Manufacturers of Inhalation Powder Budesonide, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Inhalation Powder Budesonide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhalation Powder Budesonide as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Inhalation Powder Budesonide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Inhalation Powder Budesonide Sales by Region (2019-2024) & (K Units)
Table 18. Global Inhalation Powder Budesonide Sales Market Share by Region (2019-2024)
Table 19. Global Inhalation Powder Budesonide Sales by Region (2025-2030) & (K Units)
Table 20. Global Inhalation Powder Budesonide Sales Market Share by Region (2025-2030)
Table 21. Global Inhalation Powder Budesonide Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Inhalation Powder Budesonide Revenue Market Share by Region (2019-2024)
Table 23. Global Inhalation Powder Budesonide Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Inhalation Powder Budesonide Revenue Market Share by Region (2025-2030)
Table 25. North America Inhalation Powder Budesonide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Inhalation Powder Budesonide Sales by Country (2019-2024) & (K Units)
Table 27. North America Inhalation Powder Budesonide Sales by Country (2025-2030) & (K Units)
Table 28. North America Inhalation Powder Budesonide Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Inhalation Powder Budesonide Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Inhalation Powder Budesonide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Inhalation Powder Budesonide Sales by Country (2019-2024) & (K Units)
Table 32. Europe Inhalation Powder Budesonide Sales by Country (2025-2030) & (K Units)
Table 33. Europe Inhalation Powder Budesonide Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Inhalation Powder Budesonide Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Inhalation Powder Budesonide Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Inhalation Powder Budesonide Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Inhalation Powder Budesonide Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Inhalation Powder Budesonide Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Inhalation Powder Budesonide Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Inhalation Powder Budesonide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Inhalation Powder Budesonide Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Inhalation Powder Budesonide Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Inhalation Powder Budesonide Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Inhalation Powder Budesonide Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Inhalation Powder Budesonide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Inhalation Powder Budesonide Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Inhalation Powder Budesonide Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Inhalation Powder Budesonide Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Inhalation Powder Budesonide Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Inhalation Powder Budesonide Sales (K Units) by Type (2019-2024)
Table 51. Global Inhalation Powder Budesonide Sales (K Units) by Type (2025-2030)
Table 52. Global Inhalation Powder Budesonide Sales Market Share by Type (2019-2024)
Table 53. Global Inhalation Powder Budesonide Sales Market Share by Type (2025-2030)
Table 54. Global Inhalation Powder Budesonide Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Inhalation Powder Budesonide Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Inhalation Powder Budesonide Revenue Market Share by Type (2019-2024)
Table 57. Global Inhalation Powder Budesonide Revenue Market Share by Type (2025-2030)
Table 58. Global Inhalation Powder Budesonide Price (US$/Unit) by Type (2019-2024)
Table 59. Global Inhalation Powder Budesonide Price (US$/Unit) by Type (2025-2030)
Table 60. Global Inhalation Powder Budesonide Sales (K Units) by Application (2019-2024)
Table 61. Global Inhalation Powder Budesonide Sales (K Units) by Application (2025-2030)
Table 62. Global Inhalation Powder Budesonide Sales Market Share by Application (2019-2024)
Table 63. Global Inhalation Powder Budesonide Sales Market Share by Application (2025-2030)
Table 64. Global Inhalation Powder Budesonide Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Inhalation Powder Budesonide Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Inhalation Powder Budesonide Revenue Market Share by Application (2019-2024)
Table 67. Global Inhalation Powder Budesonide Revenue Market Share by Application (2025-2030)
Table 68. Global Inhalation Powder Budesonide Price (US$/Unit) by Application (2019-2024)
Table 69. Global Inhalation Powder Budesonide Price (US$/Unit) by Application (2025-2030)
Table 70. AstraZeneca Corporation Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. AstraZeneca Inhalation Powder Budesonide Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. Teva Corporation Information
Table 76. Teva Description and Business Overview
Table 77. Teva Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Teva Inhalation Powder Budesonide Product
Table 79. Teva Recent Developments/Updates
Table 80. Mylan Corporation Information
Table 81. Mylan Description and Business Overview
Table 82. Mylan Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Mylan Inhalation Powder Budesonide Product
Table 84. Mylan Recent Developments/Updates
Table 85. Sandoz Corporation Information
Table 86. Sandoz Description and Business Overview
Table 87. Sandoz Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Sandoz Inhalation Powder Budesonide Product
Table 89. Sandoz Recent Developments/Updates
Table 90. Cosmo Pharmaceuticals Corporation Information
Table 91. Cosmo Pharmaceuticals Description and Business Overview
Table 92. Cosmo Pharmaceuticals Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Cosmo Pharmaceuticals Inhalation Powder Budesonide Product
Table 94. Cosmo Pharmaceuticals Recent Developments/Updates
Table 95. Salix Corporation Information
Table 96. Salix Description and Business Overview
Table 97. Salix Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Salix Inhalation Powder Budesonide Product
Table 99. Salix Recent Developments/Updates
Table 100. Chiesi Farmaceutici Corporation Information
Table 101. Chiesi Farmaceutici Description and Business Overview
Table 102. Chiesi Farmaceutici Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Chiesi Farmaceutici Inhalation Powder Budesonide Product
Table 104. Chiesi Farmaceutici Recent Developments/Updates
Table 105. Orion Corporation Corporation Information
Table 106. Orion Corporation Description and Business Overview
Table 107. Orion Corporation Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Orion Corporation Inhalation Powder Budesonide Product
Table 109. Orion Corporation Recent Developments/Updates
Table 110. Cipla Corporation Information
Table 111. Cipla Description and Business Overview
Table 112. Cipla Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Cipla Inhalation Powder Budesonide Product
Table 114. Cipla Recent Developments/Updates
Table 115. Synmosa Biopharma Corporation Information
Table 116. Synmosa Biopharma Description and Business Overview
Table 117. Synmosa Biopharma Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Synmosa Biopharma Inhalation Powder Budesonide Product
Table 119. Synmosa Biopharma Recent Developments/Updates
Table 120. Lunan Better Pharma Corporation Information
Table 121. Lunan Better Pharma Description and Business Overview
Table 122. Lunan Better Pharma Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Lunan Better Pharma Inhalation Powder Budesonide Product
Table 124. Lunan Better Pharma Recent Developments/Updates
Table 125. Shanghai Sine Promod Corporation Information
Table 126. Shanghai Sine Promod Description and Business Overview
Table 127. Shanghai Sine Promod Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Shanghai Sine Promod Inhalation Powder Budesonide Product
Table 129. Shanghai Sine Promod Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Inhalation Powder Budesonide Distributors List
Table 133. Inhalation Powder Budesonide Customers List
Table 134. Inhalation Powder Budesonide Market Trends
Table 135. Inhalation Powder Budesonide Market Drivers
Table 136. Inhalation Powder Budesonide Market Challenges
Table 137. Inhalation Powder Budesonide Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Inhalation Powder Budesonide
Figure 2. Global Inhalation Powder Budesonide Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Inhalation Powder Budesonide Market Share by Type in 2023 & 2030
Figure 4. 100~200 Inhalation Product Picture
Figure 5. Other Product Picture
Figure 6. Global Inhalation Powder Budesonide Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Inhalation Powder Budesonide Market Share by Application in 2023 & 2030
Figure 8. Respiratory Disease Treatment
Figure 9. Nose Disease Treatment
Figure 10. Inflammatory Bowel Disease Treatment
Figure 11. Other
Figure 12. Global Inhalation Powder Budesonide Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Inhalation Powder Budesonide Market Size (2019-2030) & (US$ Million)
Figure 14. Global Inhalation Powder Budesonide Sales (2019-2030) & (K Units)
Figure 15. Global Inhalation Powder Budesonide Average Price (US$/Unit) & (2019-2030)
Figure 16. Inhalation Powder Budesonide Report Years Considered
Figure 17. Inhalation Powder Budesonide Sales Share by Manufacturers in 2023
Figure 18. Global Inhalation Powder Budesonide Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Inhalation Powder Budesonide Players: Market Share by Revenue in 2023
Figure 20. Inhalation Powder Budesonide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Inhalation Powder Budesonide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Inhalation Powder Budesonide Sales Market Share by Country (2019-2030)
Figure 23. North America Inhalation Powder Budesonide Revenue Market Share by Country (2019-2030)
Figure 24. United States Inhalation Powder Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Inhalation Powder Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Inhalation Powder Budesonide Sales Market Share by Country (2019-2030)
Figure 27. Europe Inhalation Powder Budesonide Revenue Market Share by Country (2019-2030)
Figure 28. Germany Inhalation Powder Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Inhalation Powder Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Inhalation Powder Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Inhalation Powder Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Inhalation Powder Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Inhalation Powder Budesonide Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Inhalation Powder Budesonide Revenue Market Share by Region (2019-2030)
Figure 35. China Inhalation Powder Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Inhalation Powder Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Inhalation Powder Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Inhalation Powder Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Inhalation Powder Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Inhalation Powder Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Inhalation Powder Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Inhalation Powder Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Inhalation Powder Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Inhalation Powder Budesonide Sales Market Share by Country (2019-2030)
Figure 45. Latin America Inhalation Powder Budesonide Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Inhalation Powder Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Inhalation Powder Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Inhalation Powder Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Inhalation Powder Budesonide Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Inhalation Powder Budesonide Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Inhalation Powder Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Inhalation Powder Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Inhalation Powder Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Inhalation Powder Budesonide by Type (2019-2030)
Figure 55. Global Revenue Market Share of Inhalation Powder Budesonide by Type (2019-2030)
Figure 56. Global Inhalation Powder Budesonide Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Inhalation Powder Budesonide by Application (2019-2030)
Figure 58. Global Revenue Market Share of Inhalation Powder Budesonide by Application (2019-2030)
Figure 59. Global Inhalation Powder Budesonide Price (US$/Unit) by Application (2019-2030)
Figure 60. Inhalation Powder Budesonide Value Chain
Figure 61. Inhalation Powder Budesonide Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
